Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium
Year: 2009
Type: article
Study design: Clinical Trial
Source: British Journal of Urology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1205502904, SOUTHWEST ONCOLOGY GROUP, G1331445602, G1469275664, G2064543036, G2562936776, G268786457, COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, Southeast Cancer Control Consortium, Inc, G3337849518, City of Hope Southwest Oncology Group Clinical Trials, G3710026009, G4094841028, G413878341, G4292856267, G5125348268, G5504618518, G591690631, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, NORTHWEST COMMUNITY CLINICAL ONCOLOGY PROGRAM, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, G763325562, Kansas City Clincal Oncology Program CCOP, G860872252, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, G960417071, Montana Cancer Consortium CCOP
OpenAlex ID: W2041383926
